| First Author | Zhang SM | Year | 2014 |
| Journal | Nat Commun | Volume | 5 |
| Pages | 5160 | PubMed ID | 25319116 |
| Mgi Jnum | J:225706 | Mgi Id | MGI:5694044 |
| Doi | 10.1038/ncomms6160 | Citation | Zhang SM, et al. (2014) Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat Commun 5:5160 |
| abstractText | Interferon regulatory factor 9 (IRF9) has various biological functions and regulates cell survival; however, its role in vascular biology has not been explored. Here we demonstrate a critical role for IRF9 in mediating neointima formation following vascular injury. Notably, in mice, IRF9 ablation inhibits the proliferation and migration of vascular smooth muscle cells (VSMCs) and attenuates intimal thickening in response to injury, whereas IRF9 gain-of-function promotes VSMC proliferation and migration, which aggravates arterial narrowing. Mechanistically, we show that the transcription of the neointima formation modulator SIRT1 is directly inhibited by IRF9. Importantly, genetic manipulation of SIRT1 in smooth muscle cells or pharmacological modulation of SIRT1 activity largely reverses the neointima-forming effect of IRF9. Together, our findings suggest that IRF9 is a vascular injury-response molecule that promotes VSMC proliferation and implicate a hitherto unrecognized 'IRF9-SIRT1 axis' in vasculoproliferative pathology modulation. |
